Drug Type Molecular glue |
Synonyms |
Target |
Mechanism CK1α inhibitors(casein kinase 1 alpha 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC21H16ClF3N4O4 |
InChIKeyDGAWFEDONPXNNP-WMLDXEAASA-N |
CAS Registry2564486-44-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Myelodysplastic Syndromes | Phase 1 | CA | 02 Dec 2021 | |
Myelodysplastic Syndromes | Phase 1 | ES | 02 Dec 2021 | |
Myelodysplastic Syndromes | Phase 1 | GB | 02 Dec 2021 | |
Myelodysplastic Syndromes | Phase 1 | US | 02 Dec 2021 | |
Myelodysplastic Syndromes | Phase 1 | AU | 02 Dec 2021 | |
Relapsing acute myeloid leukemia | Phase 1 | ES | 02 Dec 2021 | |
Relapsing acute myeloid leukemia | Phase 1 | AU | 02 Dec 2021 | |
Relapsing acute myeloid leukemia | Phase 1 | CA | 02 Dec 2021 | |
Relapsing acute myeloid leukemia | Phase 1 | GB | 02 Dec 2021 | |
Relapsing acute myeloid leukemia | Phase 1 | US | 02 Dec 2021 |